CompletedNot Applicable

Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

South Korea97 participantsStarted 2018-09-04

Plain-language summary

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

Who can participate

Age range19 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 19 and 70 years * Overweight (25 kg/m2 ≤ body mass index (BMI) \< 30 kg/m2) Exclusion Criteria: * Pregnancy or breast-feeding * Unstable body weight (body weight change \> 10% within 3 months before screening)

What they're measuring

change from baseline fat percentage at 12 week

Timeframe: at baseline and 12-week follow-up

Trial details

NCT IDNCT03759743

SponsorMedy-Tox

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-08-17

View on ClinicalTrials.gov More Overweight trials